Figures computed from official regulatory filings — .
Analysttarget 3.2 USD (+1%) · consensus 3.71/5 · 4 buy · 2 hold · 1 sell
Ownershipinsiders 0.91% · institutions 71.54% · short 6.9% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Esperion Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was formerly known as HDL Therapeutics, Inc. and changed its name to Esperion Therapeutics, Inc. in May 2008. The company was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
77 buys148 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| CARROLL J MARTINtrack record | Other | n/a (No price was disclosed in the filing) | SEC |
| Shepard Jay | Other | n/a (No price was disclosed in the filing) | SEC |
| Shepard Jay | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Looker Benjamin | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| CARROLL J MARTINtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Fischer Seth H.Z. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shepard Jay | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Koenig Sheldon L. | Other | n/a (No price was disclosed in the filing) | SEC |
| HOFFMAN ROBERT | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Halladay Benjamin | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Halladay Benjamin | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Fischer Seth H.Z. | Other | n/a (No price was disclosed in the filing) | SEC |
| Fischer Seth H.Z. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THOMPSON JOHN CRAIG | Other | n/a (No price was disclosed in the filing) | SEC |
| Shepard Jay | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| THOMPSON JOHN CRAIG | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Halladay Benjamin | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOFFMAN ROBERT | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Looker Benjamin | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Fischer Seth H.Z. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Koenig Sheldon L. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| CARROLL J MARTINtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Halladay Benjamin | Other | n/a (No price was disclosed in the filing) | SEC |
| Koenig Sheldon L. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| CARROLL J MARTINtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |